BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 23478562)

  • 1. Acute mountain sickness prophylaxis: a high-altitude perspective.
    DeLellis SM; Anderson SE; Lynch JH; Kratz K
    Curr Sports Med Rep; 2013; 12(2):110-4. PubMed ID: 23478562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mountaineering and altitude sickness].
    Maggiorini M
    Ther Umsch; 2001 Jun; 58(6):387-93. PubMed ID: 11441701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.
    Bernhard WN; Schalick LM; Delaney PA; Bernhard TM; Barnas GM
    Aviat Space Environ Med; 1998 Sep; 69(9):883-6. PubMed ID: 9737760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Findings of Cognitive Impairment at High Altitude: Relationships to Acetazolamide Use and Acute Mountain Sickness.
    Phillips L; Basnyat B; Chang Y; Swenson ER; Harris NS
    High Alt Med Biol; 2017 Jun; 18(2):121-127. PubMed ID: 28509579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a 5-lipoxygenase inhibitor on acute mountain sickness and urinary leukotriene e4 after ascent to high altitude.
    Grissom CK; Richer LD; Elstad MR
    Chest; 2005 Feb; 127(2):565-70. PubMed ID: 15705997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetazolamide and high altitude diseases.
    Bradwell AR; Wright AD; Winterborn M; Imray C
    Int J Sports Med; 1992 Oct; 13 Suppl 1():S63-4. PubMed ID: 1483796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
    Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
    BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEDEX 2015: Heart Rate Variability Predicts Development of Acute Mountain Sickness.
    Sutherland A; Freer J; Evans L; Dolci A; Crotti M; Macdonald JH
    High Alt Med Biol; 2017 Sep; 18(3):199-208. PubMed ID: 28418725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention and therapy of altitude sickness].
    Maggiorini M
    Ther Umsch; 1993 Apr; 50(4):221-7. PubMed ID: 8378872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.
    Bärtsch P; Schneider M
    BMJ; 2001 Jan; 322(7277):48-9. PubMed ID: 11141168
    [No Abstract]   [Full Text] [Related]  

  • 11. Altitude illness: risk factors, prevention, presentation, and treatment.
    Fiore DC; Hall S; Shoja P
    Am Fam Physician; 2010 Nov; 82(9):1103-10. PubMed ID: 21121556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute mountain sickness prophylaxis: knowledge, attitudes, & behaviours in the Everest region of Nepal.
    Kilner T; Mukerji S
    Travel Med Infect Dis; 2010 Nov; 8(6):395-400. PubMed ID: 21112541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute mountain sickness in travelers who consulted a pre-travel clinic.
    Croughs M; Van Gompel A; Van den Ende J
    J Travel Med; 2011; 18(5):337-43. PubMed ID: 21896098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m).
    Davies AJ; Kalson NS; Stokes S; Earl MD; Whitehead AG; Frost H; Tyrell-Marsh I; Naylor J
    Wilderness Environ Med; 2009; 20(4):311-7. PubMed ID: 20030437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND; Baggott AV; Andrew Todd WT
    J Travel Med; 2012; 19(5):298-307. PubMed ID: 22943270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Day of Ascent Dosing of Acetazolamide for Prevention of Acute Mountain Sickness.
    Lipman GS; Jurkiewicz C; Winstead-Derlega C; Navlyt A; Burns P; Walker A; Phillips C; Reilly A; Burnier A; Romero J; Warner K; Hackett P
    High Alt Med Biol; 2019 Sep; 20(3):271-278. PubMed ID: 31259608
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical models of acute mountain sickness.
    Vann RD; Pollock NW; Pieper CF; Murdoch DR; Muza SR; Natoli MJ; Wang LY
    High Alt Med Biol; 2005; 6(1):32-42. PubMed ID: 15772498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
    Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
    Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier.
    Ellsworth AJ; Meyer EF; Larson EB
    West J Med; 1991 Mar; 154(3):289-93. PubMed ID: 2028586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginkgo biloba decreases acute mountain sickness in people ascending to high altitude at Ollagüe (3696 m) in northern Chile.
    Moraga FA; Flores A; Serra J; Esnaola C; Barriento C
    Wilderness Environ Med; 2007; 18(4):251-7. PubMed ID: 18076292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.